Source link : https://newshealth.biz/health-news/pd-1-inhibitor-raises-pfs-in-advanced-acral-melanoma/
(MedPage Today) — First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but statistically significant increase in progression-free survival (PFS) compared with treatment with dacarbazine… Source link : https://www.medpagetoday.com/hematologyoncology/skincancer/119251 Author : Publish date : 2026-01-02 19:17:00 Copyright for syndicated content belongs to the linked Source.
The post PD-1 Inhibitor Raises PFS in Advanced Acral Melanoma first appeared on News Health.
—-
Author : News Health
Publish date : 2026-01-02 19:17:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8